Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market

1 source1 article First seen 2 days ago Updated 2 days ago United States Truth score 43

Save Like Comments Compare coverage

Summary

CNBC’s Annika Kim Constantino and Albert Bourla, Pfizer CEO, join 'The Exchange' to discuss Pfizer's Q3 earnings, patent expirations, and more.

Description from CNBC.

Comments need JavaScript.

43/100Limited corroboration

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Centre 100%100%